Probiotic Skin Acne Meta-analysis: What the Evidence Says
Probiotic Skin Acne Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syste
Quick Answer
Probiotic Skin Acne Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 2 systematic review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Probiotic Skin Acne Meta-analysis: What the Evidence Says
Quick Answer
Probiotic Skin Acne Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Lactobacillus‐Based Microbiome Therapy for Acne Vulgaris: A GRADE Systematic Review and Meta‐Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-03-19 | 10.1111/jocd.70792 |
| The Impact of Probiotics on Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials | systematic review | 1 | 2025-11-16 | 10.7759/cureus.97010 |
What The Sources Report
- Its multifactorial pathogenesis involves increased sebum production, follicular hyperkeratinization,colonization, and inflammatory immune responses. [Abedin Zain Ul (2026); evidence level 1]
- Beyond physical manifestations, acne also impairs psychosocial health, often leading to anxiety, depression, and reduced quality of life. [Abedin Zain Ul (2026); evidence level 1]
- Concerns about antibiotic resistance, side effects of treatment, and patient compliance have, however, increased interest in other adjunctive or alternative therapies, such as probiotics. [Muacevic Alexander (2025); evidence level 1]
- Despite growing evidence of the potential benefits of probiotics in acne management, skepticism persists due to inconsistent findings across studies. [Muacevic Alexander (2025); evidence level 1]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For probiotic skin acne meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Abedin Zain Ul (2026). Lactobacillus‐Based Microbiome Therapy for Acne Vulgaris: A GRADE Systematic Review and Meta‐Analysis of Randomized Controlled Trials. DOI: 10.1111/jocd.70792. PMCID: PMC13000680. PMID: 41853869. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13000680/
- Muacevic Alexander (2025). The Impact of Probiotics on Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials. DOI: 10.7759/cureus.97010. PMCID: PMC12709052. PMID: 41416302. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12709052/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 27, 2026 by Migaku Evidence Review
Related content
